DSF2026 2000x1000 150ppi scaled | ApconiX

Translational Safety from
Small Molecules to New Modalities

We are delighted to celebrate the fourth year of our Drug Safety Forum, providing a platform for nonclinical and clinical communities to engage with current safety science and offer a future perspective. We focus on new theoretical and experimental approaches to translational safety science.

The central themes of the forum are two-fold; what more can we achieve and what new models can we access that helps us to better understand what will happen in the clinic.

As there is a limited number of places for this symposium. Registration requires a passcode.
If you would like to attend and haven’t yet received a passcode, please contact us at drug.safety.forum@apconix.com

Programme:

The format includes talks, discussion and debates, ensuring the patient remains at the centre of our thinking.

Time Title Speaker
9:00 – 9:45 Arrival and Registration
9:45 – 10:00 Introduction Dr Richard Knight
Opening Keynote
10:00 – 10:30 The UK “Replacing Animals in Science” Strategy: One Year On; Reactions and Opportunities Dr Anthony Holmes (NC3Rs)
10:30 – 10:45 Questions & Discussion
10:45 – 11:05 Bringing Safer Medicines to Patients using AI: Real World Case Studies Dr Layla Hosseini-Gerami (Ignota Labs)
11:05 – 11:15 Questions & Discussion
11:15 – 11:35 Predicting on and off target Safety Across Modalities: a Key Early Derisking Approach Dr James Sidaway (ApconiX)
11:35 – 11:45 Questions & Discussion
11:45 – 12:05 Single-Cell Mechanistic AI for Toxicology Shawn Owens (Deepcyte Bio)
12:05 – 12:15 Questions & Discussion
12:15 – 13:15 Lunch
13:15 – 13:45 Four 3 minute pitches – some latest science from ApconiX
13:45 – 13:55 Questions & Discussion
14:00 – 14:20 Reimagining Safety Assessment with New Approach Methodologies Rhiannon David (AstraZeneca)
14:20 – 14:30 Questions & Discussion
14:30 – 15:20 Artificial Intelligence and Machine Learning Applications to Safety Science for Early Derisking Dr James McDonagh (ApconiX)
15:20 – 15:30 Questions & Discussion
15:30 – 15:50 A UK Regulatory Perspective on Emerging Approaches to Nonclinical Safety Kathryn Costelloe (MHRA)
15:50 – 16:00 Questions & Discussion
16:00 Panel Discussion:
What do you think we will be highlighting at this meeting in 5 years’ time?
Chair:
Professor Ruth Roberts
17:00 Close